Updates

July 22, 2019
Antibody-Drug Conjugate Shows Efficacy in Heavily Treated Cancers

An investigational antibody-drug conjugate made of the HER2-targeting antibody trastuzumab (marketed as Herceptin and others) attached to a kind of chemotherapy compound has ... Read more
July 19, 2019
Genomic Analysis Reveals Differences Between Cancer Cell Lines and Human Cancers

New research using “big data” helps highlight the differences between breast cancer cell lines and actual patient samples. This could allow researchers to choose ... Read more
July 17, 2019
Trilaciclib-Chemo Combo Extends Lives of Triple-negative Breast Cancer Patients, Preliminary Phase 2 Findings Show

Trilaciclib, a treatment that protects the bone marrow from the damaging effects of chemotherapy, significantly extends the lives of women with metastatic triple-negative ... Read more
July 16, 2019July 11, 2019
What Cancer Taught Me About Being a Mom

I dated a guy in college who described the time he saw a nasty brown stain on his shower floor. When he called his ... Read more
July 15, 2019July 15, 2019
$20M Gift to Dana-Farber Will Establish Fund for Metastatic Breast Cancer Research

The Dana-Farber Cancer Institute will get $20 million to create the Saverin Breast Cancer Research Fund aimed at extending the lives of metastatic breast ... Read more

News

Balixafortide-Halaven Combo Seen to Prolong Survival in Advanced Breast Cancer Patients in Phase 1 Trial
July 12, 2019July 12, 2019
A combination of Polyphor‘s investigational therapy balixafortide (POL6326) and Eisai‘s Halaven (eribulin) may prolong the ...
News

Obesity Reprograms Immune Cells in Mammary Tissues to Promote Tumor Development, Study Says
July 10, 2019
Obesity in women with triple-negative breast cancer, the most aggressive kind of breast cancer, ...
News

Puma Applies to FDA to Extend Nerlynx’s Use to HER2-Positive Metastatic Breast Cancer
July 8, 2019
Puma Biotechnology is seeking to extend the use of its breast cancer medicine Nerlynx ...
News

CHMP Recommends Tecentriq-Abraxane Combination to Treat Some Triple-negative Breast Cancers in Europe
July 3, 2019
The  Committee for Medicinal Products for Human Use (CHMP),  an arm of the  European Medicines Agency , ...
A Lump in the Road - A Column by Nancy Brier, Columns

Survival Is All About the Money
July 2, 2019June 27, 2019
“It’s cancer,” my friend said. She had seen a doctor for something unrelated, but ...
News

Fujifilm Bus Hits the Road to Offer Breast Cancer Screenings and Promote Early Diagnosis
July 1, 2019July 1, 2019
Fujifilm Medical Systems USA has launched a nationwide effort to enhance access to breast ...

Subscribe to our mailing list

Get regular updates delivered to your email box.

Thanks! Please check your email for a confirmation email.

Breast Cancer Index Identifies Patients Who Will Benefit From Extended Endocrine Therapy, Data Shows
June 28, 2019
Biotheranostics‘ Breast Cancer Index can help distinguish which breast cancer patients will derive a ...
European Commission Approves Talzenna to Treat Some Breast Cancers
June 26, 2019
The European Commission (EC) has approved Pfizer‘s Talzenna (talazoparib) for the treatment of patients ...
Tecentriq-Abraxane Combo Prolonging Survival in TNBC Patients, Phase 3 Trial Data Show
June 24, 2019June 27, 2019
Anti-Diarrheal Medicines Improve Tolerability of Nerlynx in Breast Cancer Patients
June 21, 2019
Kisqali-Endocrine Therapy Combo Increases Overall Survival In Hormone Receptor-Positive Breast Cancer Patients, Study Shows
June 19, 2019
FDA Approves Herceptin Biosimilar Kanjinti for HER2-positive Breast Cancer
June 17, 2019

Susan G. Komen, Cancer Australia to Co-fund Metastatic BC Research
June 14, 2019
A new partnership between Susan G. Komen and Cancer Australia will grant a researcher ...
Combining 2 Assessments of Breast Cancer Recurrence Risk May Help Guide Use of Adjuvant Chemotherapy
June 12, 2019
How a $100 Bill Brings Me Peace of Mind
June 11, 2019June 7, 2019
Long-term Data Continue to Support Perjeta Regimen for HER2-positive Metastatic Breast Cancer
June 7, 2019

New AI-based Model Outperforms Current Methods of Predicting Breast Cancer Risk
June 5, 2019
Scientists have created a new artificial intelligence (AI)-based model that outperforms current models at ...
Chemo Resistance in TNBC Due to Molecular Changes That May Be Treatable, Study Suggests
June 3, 2019
Prestige’s HD201, a Biosimilar to Herceptin, Accepted for Review in Europe for HER2-positive BC
May 31, 2019May 31, 2019

News

FDA Approves Piqray-Faslodex Combo for Some Patients with Advanced Breast Cancer
May 29, 2019May 29, 2019
Breast cancer patients in the U.S. who are receptor positive (HR+), human epidermal growth ...
A Lump in the Road - A Column by Nancy Brier, Columns

The Blonde in the Waiting Room
May 28, 2019May 24, 2019
A young woman weeped. Pretty blond hair swung in front of her face, but ...
News

Keytruda Fails to Improve Overall Survival of Patients with Triple-Negative Breast Cancer, Phase 3 Trial Shows
May 24, 2019
Keytruda (pembrolizumab), Merck‘s anti-PD-1 checkpoint blockade immunotherapy, failed to prolong the overall survival of ...
News

Treatment Intensity Should Be Personalized in Women with HER2-positive Breast Cancer, Study Says
May 22, 2019
Personalized treatment intensity is crucial to the success of less toxic and demanding therapies ...
News

Young Women More Likely to Face Aggressive BC Types, But Proper Treatment Improves Outcomes
May 20, 2019
Young women are more likely than older ones to be diagnosed with more aggressive ...
News

Experimental Antibody Therapy Leads to Significant Responses in HER2-positive Breast Cancer, Phase 2 Trial Shows
May 15, 2019
Trastuzumab deruxtecan (DS-8201), an investigational antibody-drug conjugate developed by AstraZeneca with Daiicho Sankyo, led ...
A Lump in the Road - A Column by Nancy Brier, Columns

Here I Am
May 14, 2019May 9, 2019
I remember when my daughter performed at a talent show at her school. I’d ...
News

Radiation Therapy Reduces Chances of Breast Cancer Returning in Women with Early, Hormone-Positive Disease, Trial Shows
May 13, 2019
Women with early, low-risk hormone receptor-positive breast cancer are significantly less likely to see ...
News

Kadcyla Approved in US for Some HER2-positive Early Breast Cancer Patients
May 10, 2019
The U.S. Food and Drug Administration (FDA) has extended the use of Genentech‘s Kadcyla (ado-trastuzumab emtansine) ...
News

SHARE Introduces My MBC & Me App for Metastatic Breast Cancer Patients
May 6, 2019
Since her diagnosis of metastatic breast cancer two years ago, Karen Peterson has been ...
News

New Imaging Tool Captures Process That Turns Tumor Cells Malignant in Breast Cancer
May 3, 2019
A new imaging technique that visualizes individual cells with high resolution may improve the ...
A Lump in the Road - A Column by Nancy Brier, Columns

Walking on Broken Glass
April 30, 2019April 26, 2019
My family and I stopped to look at art this week. While we wandered ...
News

Clinical Trial Will Test Investigational Therapy Targeting ‘Dormant’ Breast Cancer Cells
April 29, 2019April 29, 2019
GlycoMimetics is planning a clinical trial testing its therapy candidate GMI-1359 as a treatment ...
News

Surgery That Removes All Traces of Breast Cancer Stimulates Protective Anticancer Immune Response, Mouse Study Suggests
April 26, 2019
Breast cancer surgery with negative or clear margins, which leaves no signs of cancer behind, ...
News

Liposomal Irinotecan Shows Promising Phase 1 Results in Heavily Treated Breast Cancer Patients
April 24, 2019
Treatment with a liposomal formulation of irinotecan — meaning the chemotherapy is wrapped up ...
News

Antibiotic in Long Use for Leprosy, Clofazimine, May Treat Triple-negative Breast Cancer, Mouse Study Suggests
April 22, 2019
Clofazimine, an antibiotic long used for treating leprosy and tuberculosis, may be repurposed as a ...
News

AstraZeneca Teams with Daiichi Sankyo to Speed Development of HER2-positive Advanced Breast Cancer Therapy
April 17, 2019
AstraZeneca is starting a collaboration with Daiichi Sankyo for the global production and commercialization of ...
A Lump in the Road - A Column by Nancy Brier, Columns

It’s Probably Nothing
April 16, 2019April 15, 2019
It’s probably not back. But if it is, it’ll kill me. Every six months, ...

June 22, 2018June 22, 2018

Clinical Trial of Tamoxifen-based Gel in Reducing Breast Density Recruiting in US, EU

News

The ability of a gel containing a tamoxifen-byproduct to reduce breast density — associated with an increased risk of breast cancer — is now being evaluated in a recruiting Phase 3 clinical trial. Approximately half of women in ... Read more

Subscribe to our mailing list

Pin It on Pinterest